ClearPoint Neuro, Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ClearPoint Neuro, Inc. stock issued during period, value, conversion of units for fiscal 2014 was $9.38M, a 44.32% increase from fiscal 2013.
- ClearPoint Neuro, Inc. stock issued during period, value, conversion of units for fiscal 2013 was $6.50M, a 82.63% increase from fiscal 2012.
- ClearPoint Neuro, Inc. stock issued during period, value, conversion of units for fiscal 2012 was $3.56M.
- ClearPoint Neuro, Inc. stock issued during period, value, conversion of units for fiscal 2010 was $2.78M.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2014-12-31 | $9.38M 10-K · filed 2015-03-17 | |
| 2013-12-31 | $6.50M 10-K · filed 2015-03-17 | |
| 2012-12-31 | $3.56M 10-K · filed 2014-03-28 | |
| 2010-12-31 | $2.78M 10-K/A · filed 2013-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |